4//SEC Filing
Anand Bhaskar 4
Accession 0001890784-26-000003
CIK 0001599298other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:01 PM ET
Size
5.6 KB
Accession
0001890784-26-000003
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
[F2][F1]2026-01-08+30,000→ 30,000 totalExercise: $18.83Exp: 2036-01-08→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The option was granted on January 8, 2026. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on January 8, 2027.
- [F2]Not applicable.
Signature
/s/ Bhaskar Anand|2026-01-12
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001890784
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:01 PM ET
- Size
- 5.6 KB